AGI Biopharmaceuticals

United States
Indiana, Pennsylvania, United States

Company profile

AGI Biopharmaceuticals company profile

AGI Biopharmaceuticals, Ltd., a European firm that has developed a patented, economic, melanoma vaccine with future multi-cancer application.

Business identity

Operating status
Active
Company type
For Profit
Employee range
11-50 employees
Founded
2009-01-01, Year

Headquarters

Country code
US
Continent
North America

Capital profile

Funding and company signals

Funding rounds
1
Total equity funding
$4.7M
Last funding
Series Unknown / $4.7M / 2011-11-28
Last equity funding
Series Unknown / $4.7M
Investors
1
Lead investors
1

Founders and investors

Lead investors

Mentor Capital Partners

Investors

Mentor Capital Partners